Jean-Paul Clozel
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Der Actelion-Gründer hat alle seine Ziele erreicht – und beginnt von vorn | NZZ
Jean-Paul Clozel | EY - Global
Actelion - Wikipedia
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Actelion: independent thinking | Financial Times
Profile: Jean-Paul Clozel | Nature Biotechnology
Actelion Could Boost Takeover Price for Johnson & Johnson
Big Boss - Jean-Paul Clozel | TV5MONDE Europe
Jean-Paul Clozel
Jean-Paul Clozel: «Idorsia steht nicht zum Verkauf» | Finanz und Wirtschaft
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Actelion CEO and founder Jean-Paul Clozel attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Photo Stock - Alamy
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Actelion Chief Executive Officer Jean-Paul Clozel poses at the Forbes... News Photo - Getty Images
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
